Published in Retina on October 01, 2008
Choroidal thickness and high myopia: a cross-sectional study and meta-analysis. BMC Ophthalmol (2015) 1.02
Choroidal thickness and biometric markers for the screening of lacquer cracks in patients with high myopia. PLoS One (2013) 0.84
Sensitivity of fluorescein angiography alone or with SD-OCT for the diagnosis of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2013) 0.83
Genetic factors for choroidal neovascularization associated with high myopia. Invest Ophthalmol Vis Sci (2012) 0.82
The analysis of lacquer crack in the assessment of myopic choroidal neovascularization. Eye (Lond) (2011) 0.80
Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application. Drug Des Devel Ther (2015) 0.77
Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes. PLoS One (2016) 0.75
Insight into high myopia and the macula. Indian J Ophthalmol (2017) 0.75
Multimodal imaging including spectral-domain optical coherence tomography and confocal near-infrared reflectance for characterization of lacquer cracks in highly myopic eyes. Eye (Lond) (2014) 0.75
[Unusual myopic fundus alteration]. Ophthalmologe (2009) 0.75
Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med (2004) 4.91
Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci (2009) 3.68
Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development. Nat Neurosci (2003) 3.08
Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol (2002) 2.59
Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol (2010) 2.39
Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci (2008) 2.35
Math3 and NeuroD regulate amacrine cell fate specification in the retina. Development (2002) 2.07
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology (2008) 1.96
Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology (2009) 1.96
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology (2007) 1.81
A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology (2009) 1.80
Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation (2004) 1.76
Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2009) 1.75
Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. Am J Ophthalmol (2009) 1.60
Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol (2008) 1.59
Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol (2008) 1.55
Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature (2003) 1.55
Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration. Retina (2012) 1.53
Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol (2007) 1.53
Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2. FEBS Lett (2004) 1.51
Chandelier retroillumination-assisted torsional oscillation for cataract surgery in patients with severe corneal opacity. J Cataract Refract Surg (2007) 1.46
Nonaxoplasmic transfer of indocyanine green into the optic nerve after intravitreal application. Retina (2004) 1.44
Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J Clin Invest (2011) 1.44
Potent retinal arteriolar traction as a possible cause of myopic foveoschisis. Am J Ophthalmol (2005) 1.43
Histological evaluation of mechanical epithelial separation in epithelial laser in situ keratomileusis. J Cataract Refract Surg (2009) 1.40
PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes (2002) 1.39
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology (2009) 1.37
Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. FASEB J (2005) 1.37
Correlation of fundus autofluorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthalmol (2010) 1.35
Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol (2006) 1.34
Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis (2007) 1.33
N-Cadherin is expressed by putative stem/progenitor cells and melanocytes in the human limbal epithelial stem cell niche. Stem Cells (2006) 1.33
Limbal epithelial side-population cells have stem cell-like properties, including quiescent state. Stem Cells (2005) 1.33
Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol (2003) 1.30
Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. Ophthalmology (2008) 1.28
Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2012) 1.28
Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.27
Tractional internal limiting membrane detachment in highly myopic eyes. Am J Ophthalmol (2006) 1.25
Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology (2008) 1.23
Wavefront aberrations measured with Hartmann-Shack sensor in patients with keratoconus. Ophthalmology (2002) 1.22
Higher-order aberrations due to the posterior corneal surface in patients with keratoconus. Invest Ophthalmol Vis Sci (2008) 1.21
Magnitude and orientation of Zernike terms in patients with keratoconus. Invest Ophthalmol Vis Sci (2007) 1.20
Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Am J Ophthalmol (2009) 1.19
Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol (2008) 1.18
Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 1.17
Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PLoS One (2012) 1.17
Bacteriologic profile of the conjunctiva in the patients with dry eye. Am J Ophthalmol (2008) 1.17
Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol (2004) 1.17
Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci (2004) 1.16
Effect of transcorneal electrical stimulation in patients with nonarteritic ischemic optic neuropathy or traumatic optic neuropathy. Jpn J Ophthalmol (2006) 1.15
Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration. J Cell Sci (2012) 1.15
Wide-angle viewing lens for vitrectomy. Am J Ophthalmol (2004) 1.14
Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci (2008) 1.13
Evaluation of phosphenes elicited by extraocular stimulation in normals and by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (2007) 1.12
Retinal vascular microfolds in highly myopic eyes. Am J Ophthalmol (2005) 1.11
Generation of a transgenic rabbit model of retinal degeneration. Invest Ophthalmol Vis Sci (2008) 1.11
Changes of ocular aberration with accommodation. Am J Ophthalmol (2002) 1.11
Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol (2010) 1.11
Age-related changes in ocular and corneal aberrations. Am J Ophthalmol (2004) 1.10
Characteristics of central serous chorioretinopathy complicated by focal choroidal excavation. Retina (2014) 1.10